To understand the role of RA signaling in CD133+ hCSCs, we first used flow cytometry to examine the percentages of CD133+ cells in different hepatic carcinoma cell lines (HepG2, Huh-7 and PLC-PRF-5). This evidence concerns the gene PROM1 and hepatocellular carcinoma.